Chengyi Pharmaceutical announced that the company held a board of directors meeting on September 29, 2024 to review and approve the share repurchase plan through centralized bidding transactions. The repurchase capital is not less than 50 million yuan and not more than 0.1 billion yuan, and the repurchase price is not more than 9.66 yuan/share. The repurchase period is 12 months from the date of review and approval by the board of directors. As of November 6, 2024, the company has repurchased 3.8651 million shares, accounting for 1.18% of the total share capital, and the total payment amount is 31.5585 million yuan. Recently, the company agreed with the branch office of China Construction Bank Co., Ltd. to obtain a special loan amount of no more than 50 million yuan for stock repurchase, with a loan period of 1 year.